nsv6314404
- Organism: Homo sapiens
- Study:nstd102 (Clinical Structural Variants)
- Variant Type:complex chromosomal rearrangement
- Method Type:Multiple
- Submitted on:GRCh37
- Variant Calls:2
- Validation:Not tested
- Clinical Assertions: Yes
- Region Size:1
- Description:
46;XX;t(2;8)(q33;p21)dn AND multiple conditions - Publication(s):Redin et al. 2016
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 102 SVs from 18 studies. See in: genome view
Overlapping variant regions from other studies: 102 SVs from 18 studies. See in: genome view
Overlapping variant regions from other studies: 115 SVs from 18 studies. See in: genome view
Overlapping variant regions from other studies: 115 SVs from 18 studies. See in: genome view
Overlapping variant regions from other studies: 102 SVs from 18 studies. See in: genome view
Overlapping variant regions from other studies: 102 SVs from 18 studies. See in: genome view
Overlapping variant regions from other studies: 115 SVs from 18 studies. See in: genome view
Overlapping variant regions from other studies: 115 SVs from 18 studies. See in: genome view
Variant Region Placement Information
Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Start | Stop | strand |
---|---|---|---|---|---|---|---|---|---|---|
nsv6314404 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000002.12 | Chr2 | 199,227,700 | 199,227,700 | + |
nsv6314404 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000002.12 | Chr2 | 199,227,701 | 199,227,701 | - |
nsv6314404 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000008.11 | Chr8 | 18,716,567 | 18,716,567 | - |
nsv6314404 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000008.11 | Chr8 | 18,716,568 | 18,716,568 | + |
nsv6314404 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000002.11 | Chr2 | 200,092,423 | 200,092,423 | + | ||
nsv6314404 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000002.11 | Chr2 | 200,092,424 | 200,092,424 | - | ||
nsv6314404 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000008.10 | Chr8 | 18,574,077 | 18,574,077 | - | ||
nsv6314404 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000008.10 | Chr8 | 18,574,078 | 18,574,078 | + |
Variant Call Information
Variant Call ID | Type | Method | Analysis | Subject Phenotype | Clinical Interpretation | Source of Interpretation | ClinVar ID |
---|---|---|---|---|---|---|---|
nssv17968615 | interchromosomal translocation | Multiple | Multiple | Abnormal nervous system physiology; Abnormal nervous system physiology; EEG abnormality; EEG abnormality; Expressive language delay; Expressive language delay; Growth delay; Growth delay; Intellectual disability, severe; Intellectual disability, severe; Receptive language delay; Receptive language delay | Likely pathogenic | ClinVar | RCV000258521.1, VCV000267896.1 |
nssv17968616 | interchromosomal translocation | Multiple | Multiple | Abnormal nervous system physiology; Abnormal nervous system physiology; EEG abnormality; EEG abnormality; Expressive language delay; Expressive language delay; Growth delay; Growth delay; Intellectual disability, severe; Intellectual disability, severe; Receptive language delay; Receptive language delay | Likely pathogenic | ClinVar | RCV000258521.1, VCV000267896.1 |
Variant Call Placement Information
Variant Call ID | Placement Type | Score | Assembly | Reciprocity | Sequence ID | Chr | Start | Stop | strand |
---|---|---|---|---|---|---|---|---|---|
nssv17968615 | Remapped | Perfect | GRCh38.p12 | First Pass | NC_000002.12 | Chr2 | 199,227,700 | 199,227,700 | + |
nssv17968616 | Remapped | Perfect | GRCh38.p12 | First Pass | NC_000002.12 | Chr2 | 199,227,701 | 199,227,701 | - |
nssv17968615 | Remapped | Perfect | GRCh38.p12 | First Pass | NC_000008.11 | Chr8 | 18,716,567 | 18,716,567 | - |
nssv17968616 | Remapped | Perfect | GRCh38.p12 | First Pass | NC_000008.11 | Chr8 | 18,716,568 | 18,716,568 | + |
nssv17968615 | Submitted genomic | GRCh37 (hg19) | NC_000002.11 | Chr2 | 200,092,423 | 200,092,423 | + | ||
nssv17968616 | Submitted genomic | GRCh37 (hg19) | NC_000002.11 | Chr2 | 200,092,424 | 200,092,424 | - | ||
nssv17968615 | Submitted genomic | GRCh37 (hg19) | NC_000008.10 | Chr8 | 18,574,077 | 18,574,077 | - | ||
nssv17968616 | Submitted genomic | GRCh37 (hg19) | NC_000008.10 | Chr8 | 18,574,078 | 18,574,078 | + |
No validation data were submitted for this variant
Clinical Assertions
Variant Call ID | Type | Allele Origin | Subject Phenotype | Clinical Interpretation | Source of Interpretation | ClinVar ID |
---|---|---|---|---|---|---|
nssv17968615 | interchromosomal translocation | de novo | Abnormal nervous system physiology; Abnormal nervous system physiology; EEG abnormality; EEG abnormality; Expressive language delay; Expressive language delay; Growth delay; Growth delay; Intellectual disability, severe; Intellectual disability, severe; Receptive language delay; Receptive language delay | Likely pathogenic | ClinVar | RCV000258521.1, VCV000267896.1 |
nssv17968616 | interchromosomal translocation | de novo | Abnormal nervous system physiology; Abnormal nervous system physiology; EEG abnormality; EEG abnormality; Expressive language delay; Expressive language delay; Growth delay; Growth delay; Intellectual disability, severe; Intellectual disability, severe; Receptive language delay; Receptive language delay | Likely pathogenic | ClinVar | RCV000258521.1, VCV000267896.1 |